---
permalink: /
title: "ðŸ‘‹ Hello there, I'm Khalid!"
author_profile: true
redirect_from: 
  - /about/
  - /about.html
---


I am a PhD candidate in **Biomedical Engineering (concentration in Medical Imaging)** at **Illinois Institute of Technology**, working under the supervision of **[Prof. Konstantinos Arfanakis](https://www.iit.edu/directory/people/konstantinos-arfanakis)** in the **[MRIIT](https://www5.iit.edu/~mri/Home.html)** Lab, which is part of the **Medical Imaging & Artificial Intelligence Research Center**, and collaborating with the **[Rush Alzheimerâ€™s Disease Center](https://www.rushu.rush.edu/research-rush-university/departmental-research/rush-alzheimers-disease-center)** on age-related neuropathologies.

My research focuses on **autopsy-validated MRI, PET, and blood-based biomarkers** to characterize:
- Alzheimerâ€™s disease neuropathologic change (**ADNC**)
- Limbic-predominant age-related TDP-43 encephalopathy neuropathologic change (**LATE-NC**)
- **Cerebral small vessel diseases** like Arteriolosclerosis, Atherosclerosis and Cerebral Amyloid Angiopathy (CAA)

## What I do

Broadly, I develop **machine learning models** and **method pipelines** that link **in-vivo and ex-vivo MRI** with **neuropathology** and **cognition**, with the goal of building deployable biomarkers that generalize across **scanners, sites, and cohorts**.

This includes work on:
- MRIâ€‘based markers of **neurofibrillary tangles**, translating autopsyâ€‘grounded signatures into tools that can be used in living cohorts. 
- Quantifying brain structure and atrophy patterns to separate and combine the effects of **Alzheimerâ€™s disease**, **LATE**, and **cerebrovascular diseases**.
- Tracking **vascular** and **neurodegenerative diseases** over time, integrating **imaging** and **blood biomarkers** to understand progression and its impact on **cognition**.

---

## Iâ€™m excited about places where these tools can be used to

- Clean up heterogeneity in **Alzheimerâ€™s and mixed-pathology trials**
- Design efficient **MRI- and blood-based screening and staging** strategies
- Translate pathology-grounded imaging markers into robust, **containerized software** that collaborators can run on their own infrastructure

---

## Connect

Iâ€™m now open to postdoc and research scientist roles in neuroimaging, biomarkers, and clinical ML. If youâ€™re working on multimodal aging/AD cohorts, Iâ€™d love to connect.

